Table 1.
Authors [Reference] | Year | Sample size | Menstrual phases studied | Significant effect of menstrual phase | Significant effects in PMDD (versus NC) |
---|---|---|---|---|---|
Parry et al. [45] | 1989 | n = 8 healthyn = 8 PMS | early-FP | In healthy and PMS: variation of stage 3 (min) and intermittent awakening across cycle | ↑ stage 2 (%) across cycle |
late-FP | |||||
early-LP | ↓ REM (min, %) across cycle | ||||
late-LP | |||||
| |||||
Lee et al. [46] | 1990 | n = 6 healthy | FP | none | ↓ SWS (%) at both phases |
n = 7 symptomatic | LP | ↓ latency to stage 1 in LP | |||
| |||||
Ito et al. [47] | 1993 | n = 7 healthy | menses | ↓ SWS (min) during early-LP and late-LP | N/A |
late-FP | |||||
early-LP | |||||
late-LP | |||||
| |||||
Ishizuka et al. [48] | 1994 | n = 5 healthy | 3 nights/week across full cycle | ↑ SFA during late-LP | N/A |
| |||||
Driver et al. [49] | 1996 | n = 9 healthy | menses | ↑ NREM (%) during LP | N/A |
early-FP | |||||
mid-FP | ↑ stage 2 (%) during LP | ||||
late-FP | |||||
ovulation | ↓ REM (% NREM-REM cycle duration) during LP | ||||
early-LP | |||||
mid-LP | ↑ SFA during LP | ||||
late-LP | |||||
| |||||
Chuong et al. [50] | 1997 | n = 6 healthyn = 3 PMS | mid-FP | none | none |
ovulation | |||||
mid-LP | |||||
| |||||
Baker et al. [51] | 1999 | n = 10 healthy | menses mid-FP mid-LP | ↓ REM (%) during mid-LP versus mid-FP ↓ latency to stage 3 during mid-LP versus menses | N/A |
| |||||
Parry et al. [52] | 1999 | n = 18 healthyn = 23 PMDD | mid-FPlate-LP | In healthy and PMDD: ↑ ROL, ↓ stage 3 (min and %), and ↓ REM (min) during late-LPIn healthy: ↑ stage 1 (min, %) during late-LP | none |
| |||||
Shibui et al. [37] | 2000 | n = 8 healthy | FP | ↑ number of SWS-containing naps during LP | N/A |
LP | |||||
| |||||
Baker et al. [43] | 2001 | n = 9 healthy | mid-FP | none | N/A |
mid-LP | |||||
| |||||
Baker et al. [53] | 2002 | n = 13 healthy | mid-FP | ↓ REM (%) during mid-LP | N/A |
mid-LP | ↑ SWS (%) during mid-LP | ||||
| |||||
Driver et al. [54] | 2005 | n = 11 healthy | FPLP | ↑ stage 2 (%) during LP | N/A |
| |||||
Baker et al. [55] | 2007 | n = 12 healthyn = 9 PMS/PMDD | mid-FP late-LP | In healthy and PMS:↑ WASO (min), ↑ microaraousals/hour, and ↑ SFA during late-LP | ↑ ROL (min) at both phases |
| |||||
Lamarche et al. [56] | 2007 | n = 8 healthyn = 10 PMS | FP late-LP | In healthy and PMS: ↑ stage 2 (%),↓ SWS (%), and ↓ REM (%) during late-LP | none |
PMS: premenstrual syndrome; PMDD: premenstrual dysphoric disorder; FP: follicular phase; LP: luteal phase; REM: rapid eye movement sleep; ROL: REM onset latency; NREM: non-REM sleep; SWS: slow wave sleep; SFA: spindle frequency activity; WASO: wake after sleep onset.